Kainate Receptor Agonists, Antagonists and Allosteric Modulators

Authors: Bleakman, D.; Gates, M.R.; Ogden, A.M.; Mackowiak, M.

Source: Current Pharmaceutical Design, Volume 8, Number 10, 1 May 2002 , pp. 873-885(13)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

Price: $63.10 plus tax (Refund Policy)

Abstract:

Interest in kainate receptors has increased over the past few years. Our understanding of their physiology and pharmacology has improved markedly since their original cloning and expression in the early 1990s. For example, agonist profiles at recombinant kainate receptors have been used to identify and distinguish kainate receptors in neurons. Furthermore, the development of selective antagonists for kainate receptor subtypes has increased our understanding of the functional roles of kainate receptors in neurons and synaptic transmission.

In this review we described the activity of agonists and antagonists at kainate receptors and their selectivity profiles at NMDA and non-NMDA receptors.

Keywords: kainate receptors; nmda; non-nmda receptors; native kainate receptors; kainate receptor agonists; gamma glutamate analogues; willardiines

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1381612024607108

Publication date: 2002-05-01

More about this publication?

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.